{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T03:16:22Z","timestamp":1768619782144,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.bone.2006.01.151","type":"journal-article","created":{"date-parts":[[2006,3,14]],"date-time":"2006-03-14T14:28:25Z","timestamp":1142346505000},"page":"S7-S12","source":"Crossref","is-referenced-by-count":26,"special_numbering":"S1","title":["Ibandronate: Pharmacology and preclinical studies"],"prefix":"10.1016","volume":"38","author":[{"given":"R.G.G.","family":"Russell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2006.01.151_bib1","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1126\/science.165.3899.1262","article-title":"Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo","volume":"165","author":"Fleisch","year":"1969","journal-title":"Science"},{"key":"10.1016\/j.bone.2006.01.151_bib2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/er.19.1.80","article-title":"Bisphosphonates: mechanisms of action","volume":"19","author":"Fleisch","year":"1998","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bone.2006.01.151_bib3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2165\/00024677-200201040-00006","article-title":"Modern therapy for Paget's disease of bone: focus on bisphosphonates","volume":"1","author":"Devogelaer","year":"2002","journal-title":"Treat Endocrinol."},{"key":"10.1016\/j.bone.2006.01.151_bib4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1023\/A:1014795216669","article-title":"Bisphosphonates in the treatment of metastatic breast cancer","volume":"6","author":"Body","year":"2001","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.bone.2006.01.151_bib5","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJMoa044241","article-title":"Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease","volume":"353","author":"Reid","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2006.01.151_bib6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.4158\/EP.9.6.544","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003","volume":"9","author":"Hodgson","year":"2003","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.bone.2006.01.151_bib7","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1359\/JBMR.040325","article-title":"Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis","volume":"19","author":"Chesnut","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2006.01.151_bib8","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years' experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2006.01.151_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women","volume":"344","author":"McClung","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2006.01.151_bib10","unstructured":"Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, Office of the Surgeon General, 2004. www.surgeongeneral.gov\/library."},{"key":"10.1016\/j.bone.2006.01.151_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF02196199","article-title":"The influence of pyrophosphate, condensed phosphates, phosphonates and other phosphate compounds on the dissolution of hydroxyapatite in vitro and on bone resorption induced by parathyroid hormone in tissue culture and in thyroparathyroidectomised rats","volume":"6","author":"Russell","year":"1970","journal-title":"Calcif. Tissue Res."},{"key":"10.1016\/j.bone.2006.01.151_bib12","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/jbmr.5650111016","article-title":"Dissociation of binding and antiresorptive properties of hydroxybisphosphonates by substitution of the hydroxyl with an amino group","volume":"11","author":"Van Beek","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2006.01.151_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02405012","article-title":"Structure\u2013activity relationships of various bisphosphonates","volume":"35","author":"Shinoda","year":"1983","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2006.01.151_bib14","first-page":"265","article-title":"Bisphosphonates: structure\u2013activity relationships and therapeutic implications","volume":"vol. 8","author":"Geddes","year":"1994"},{"key":"10.1016\/j.bone.2006.01.151_bib15","article-title":"Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite","author":"Nancollas","year":"2005","journal-title":"Bone"},{"issue":"Suppl 1","key":"10.1016\/j.bone.2006.01.151_bib16","first-page":"S396","article-title":"Potential bone mineral binding differences among bisphosphonates can be demonstrated by the use of hydroxyapatite column chromatography","volume":"20","author":"Lawson","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2006.01.151_bib17","series-title":"Symposium Cemo, Centre D'Etude des Maladies Osteoarticulatires de Geneve (IV), 1\u201319. 1982","first-page":"7","article-title":"The physical chemistry of the diphosphonates-Its relationship to their medical activity","author":"Benedict","year":"1990"},{"key":"10.1016\/j.bone.2006.01.151_bib18","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/jbmr.5650090521","article-title":"Preclinical pharmacology of CGP 42'446, a new, potent, heterocyclic bisphosphonate compound","volume":"9","author":"Green","year":"1994","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2006.01.151_bib19","series-title":"Bisphosphonates on bones","first-page":"139","article-title":"Bisphosphonate antiresorptive structure\u2013activity relationships","author":"Ebetino","year":"1995"},{"issue":"Suppl 1","key":"10.1016\/j.bone.2006.01.151_bib20","first-page":"S259","article-title":"A computational model delineates differences in hydroxyapatite binding affinities of bisphosphonates in clinical use","volume":"20","author":"Ebetino","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2006.01.151_bib21","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L","article-title":"Cellular and molecular mechanism of action of bisphosphonates","volume":"88","author":"Rogers","year":"2000","journal-title":"Cancer"},{"issue":"Suppl 2","key":"10.1016\/j.bone.2006.01.151_bib22","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1007\/PL00004164","article-title":"Bisphosphonates: pharmacology, mechanisms of action and clinical uses","volume":"9","author":"Russell","year":"1999","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2006.01.151_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S8756-3282(99)00116-7","article-title":"Bisphosphonates: from the laboratory to the clinic and back again","volume":"25","author":"Russell","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.bone.2006.01.151_bib24","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI6800","article-title":"Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin","volume":"104","author":"Plotkin","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2006.01.151_bib25","doi-asserted-by":"crossref","first-page":"7317","DOI":"10.1074\/jbc.M412817200","article-title":"Bisphosphonates and estrogens inhibit osteocyte apoptosis via distinct molecular mechanisms downstream of extracellular signal-regulated kinase activation","volume":"280","author":"Plotkin","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2006.01.151_bib26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1042\/bj3030303","article-title":"Incorporation of bisphosphonates into adenine nucleotides by amoebae of the cellular slime mould Dictyostelium discoideum","volume":"303","author":"Rogers","year":"1994","journal-title":"Biochem. J."},{"issue":"Suppl 1","key":"10.1016\/j.bone.2006.01.151_bib27","first-page":"S95","article-title":"Human farnesyl diphosphate synthase (FDPS): crystal structure and molecular interactions with nitrogen-containing bisphosphonates","volume":"20","author":"Kavanagh","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2006.01.151_bib28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0022-3565(24)38786-5","article-title":"Structure\u2013activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates","volume":"296","author":"Dunford","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bone.2006.01.151_bib29","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1016\/j.jorganchem.2005.03.005","article-title":"Molecular interaction of nitrogen-containing bisphosphonates within farnesyl diphosphate synthase","volume":"690","author":"Ebetino","year":"2005","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bone.2006.01.151_bib30","first-page":"990","article-title":"Total administered dose of ibandronate determines its effects on bone mass and architecture in ovariectomized aged rats","volume":"29","author":"Bauss","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bone.2006.01.151_bib31","first-page":"2200","article-title":"Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats","volume":"29","author":"Bauss","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bone.2006.01.151_bib32","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00198-004-1612-7","article-title":"Ibandronate in osteoporosis: preclinical data and rationale for intermittent dosing","volume":"15","author":"Bauss","year":"2004","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2006.01.151_bib33","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/jbmr.5650060915","article-title":"BM 21.0955, a potent new bisphosphonate to inhibit bone resorption","volume":"6","author":"M\u00fchlbauer","year":"1991","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2006.01.151_bib34","series-title":"Guidelines for preclinical and clinical evaluation of agents used in the prevention or treatment of postmenopausal osteoporosis","year":"1994"},{"key":"10.1016\/j.bone.2006.01.151_bib35","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1359\/jbmr.1999.14.10.1768","article-title":"Intermittent and continuous administration of the bisphosphonate ibandronate in ovariohysterectomized beagle dogs: effects on bone morphometry and mineral properties","volume":"14","author":"Monier-Faugere","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2006.01.151_bib36","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1359\/jbmr.2001.16.10.1871","article-title":"Ibandronate: a comparison of oral daily dosing versus intermittent dosing in postmenopausal osteoporosis","volume":"16","author":"Riis","year":"2001","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2006.01.151_bib37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S8756-3282(02)00923-7","article-title":"Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeys","volume":"32","author":"Smith","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.bone.2006.01.151_bib38","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1172\/JCI116872","article-title":"The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates","volume":"92","author":"Balena","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2006.01.151_bib39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF02672503","article-title":"Lifelong administration of high doses of ibandronate increases bone mass and maintains bone quality of lumbar vertebrae in rats","volume":"8","author":"Lalla","year":"1998","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2006.01.151_bib40","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","article-title":"Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib","volume":"15","author":"Mashiba","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2006.01.151_bib41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.vascn.2003.11.003","article-title":"New model for simulation of fracture repair in full-grown beagle dogs: model characterization and results from a long-term study with ibandronate","volume":"50","author":"Bauss","year":"2004","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.bone.2006.01.151_bib42","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bone.2004.12.017","article-title":"The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized rats","volume":"37","author":"Kurth","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.bone.2006.01.151_bib43","first-page":"1","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"17","year":"2000","journal-title":"NIH Consens. Statement"},{"key":"10.1016\/j.bone.2006.01.151_bib44","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1359\/JBMR.040809","article-title":"Intermittent ibandronate preserves bone quality and bone strength in the lumbar spine after 16\u00a0months of treatment in the ovariectomized cynomolgus monkey","volume":"19","author":"M\u00fcller","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2006.01.151_bib45","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF01320915","article-title":"Continuous alendronate treatment throughout growth, maturation, and aging in the rat results in increases in bone mass and mechanical properties","volume":"53","author":"Guy","year":"1993","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2006.01.151_bib46","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/jbmr.5650071207","article-title":"Effects of 4-amino-1-hydroxybutylidene bisphosphonate on bone biomechanics in rats","volume":"7","author":"Toolan","year":"1992","journal-title":"J. Bone Miner. Res."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328206002249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328206002249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:32:22Z","timestamp":1736296342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328206002249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S8756328206002249"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2006.01.151","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}